Latest Headlines

  1. Microbix Antigen-Test QAPs Now Available For Clinical Use 3/11/2021

    Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, announces the availability of more of its Quality Assessment Products (QAPs™) as In-Vitro Diagnostic “IVD” Controls – to monitor the workflow accuracy of antigen-based tests for the virus causing COVID-19 disease in Canada, the EU, and the United States.

  2. Non-Invasive Liquid Biopsy To Help Cancer Diagnosis Gets CE Certification 3/11/2021

    Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformité Européenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management.

  3. Scitara Corporation Brings Life Sciences Industry A New Level Of Lab Integration With Digital Lab Exchange (DLX) 1.0 3/10/2021

    Scitara Corporation, a pioneer in digital transformation and IoLT and an emerging leader in delivering data connectivity to scientific laboratories, today announced version 1.0 of its Scitara Digital Lab Exchange (DLX) SaaS cloud platform which dramatically advances the state of data connectivity and automation in scientific laboratories.

  4. Rapid, Direct Mass Spectrometry Characterisation Of Difficult Samples 3/10/2021

    The ionRocket from BioChromato Inc. is a temperature-heating device for direct thermal desorption and pyrolysis of samples, prior to ionization and analysis by mass spectrometry.

  5. PCR Biosystems Launches Advanced Bst Polymerase Reagents For Accelerated DNA And RNA Amplification 3/10/2021

    PCR Biosystems, the UK-based specialists in DNA and RNA analysis, have launched a range of IsoFast Bst Polymerase reagents for rapid, robust and sensitive DNA and RNA amplification. Through its nucleic acid strand displacement capabilities, Bst polymerase eliminates the need for the high temperature denaturation step associated with traditional Taq enzymes.

  6. AHN Cancer Institute Opens Genomics Facility Offering Patients Next-Generation Gene Sequencing To Guide Treatment Decisions 3/9/2021

    Allegheny Health Network (AHN) Cancer Institute has opened a new Clinical Genomics Laboratory on Pittsburgh’s North Side, offering comprehensive, advanced, in-house genomic testing that guides doctors in selecting treatments to give cancer patients their best chance at a good outcome.

  7. Medical Diagnostic Laboratories, L.L.C., Announces New Line Of Urology Testing Including Prostate Cancer And Renal Cancer Hereditary Genetics 3/9/2021

    Medical Diagnostic Laboratories, L.L.C., (MDL), member of Genesis Biotechnology Group® (GBG) and CLIA-certified, CAP-accredited laboratory specializing in high-complexity, state-of-the-art, automated DNA-based molecular analyses, launched a new line of testing for the field of Urology.

  8. LabVantage Adds Vendor Validation To Its Software-As-A-Service LIMS 3/8/2021

    LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced it has added validation to a number of its subscription-based LIMS.

  9. PathAI And Labcorp Broaden Strategic Collaboration To Accelerate Use Of AI-Powered Pathology 3/8/2021

    PathAI, a global provider of artificial intelligence-powered (AI-powered) technology for use in pathology research, and Labcorp (NYSE: LH), a leading global life sciences company, today announced the broadening of their strategic partnership in the field of AI-powered pathology.

  10. Quest Diagnostics And Mercy Broaden Access To Innovative, Convenient Lab Services In The Midwest 3/8/2021

    Quest Diagnostics (NYSE: DGX), the leading provider of diagnostic information services, and Mercy, one of the nation's most highly integrated, multi-state health care systems, today announced a definitive agreement for Quest to acquire the outreach laboratory services business of Mercy in an all-cash asset transaction.